Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Fatty Acid Radiotracer Comparison Study in Heart Failure Patients [EARLY_Phase 1]
A Phase 1 early trial comparing fatty acid radiotracers in heart failure patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients [Phase 2]
Phase 2 trial evaluating intramyocardial injection of mesenchymal precursor cells in LVAD recipients for safety and efficacy on myocardial f…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients [Phase 3]
A Phase 3 trial evaluating rivaroxaban (JNJ-39039039) for reducing venous thromboembolism risk after hospital discharge; study completed wit…
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study [Phase 4]
Phase 4 trial update on goal-directed afterload reduction for acute congestive cardiac decompensation in acute heart failure.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Sequential Nephron Blockade in Acute Heart Failure [Phase 3]
Phase 3 clinical trial update for sequential nephron blockade in acute heart failure is reported, with the study status currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals Inc., enabling continued marketing of the product and …
-
FDA approval · 2019-11-14FDA Approved: SPIRONOLACTONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA has approved a supplemental application for spironolactone from Jubilant Cadista Pharmaceuticals Inc. under the ANDA framework.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Reveal LINQ™ Heart Failure
Clinical trial update for Reveal LINQ implantable monitor in heart failure shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure [Phase 4]
Phase 4 clinical trial comparing oral or intravenous thiazides to tolvaptan in diuretic-resistant decompensated heart failure has completed …
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Heart Failure Medication Adherence [NA]
A completed clinical trial evaluating medication adherence in heart failure patients; results posted in 2019.
-
FDA approval · 2019-11-06FDA Approved: VALSARTAN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for valsartan from Ascend Laboratories, updating the regulatory status of this generic antihypertens…
-
FDA approval · 2019-11-01FDA Approved: QUINAPRIL — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for quinapril filed by Solco Healthcare US, LLC under ANDA205823.
-
FDA approval · 2019-11-01FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Sun Pharmace…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Treatment of Diabetes in Patients With Systolic Heart Failure [Phase 4]
Phase 4 clinical trial update on treating diabetes in patients with systolic heart failure; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: A Pilot Study of Interventricular Septal Puncture for Cardiac Resynchronization Therapy to Treat Heart Failure [NA]
Pilot study results for interventricular septal puncture as a method to enable cardiac resynchronization therapy in heart failure patients h…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients [Phase 4]
Phase 4 clinical trial evaluating the effect of tolvaptan on mid- to long-term prognosis in heart failure patients has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Myocardial Lipid and Creatine of Heart Failure on MRS
A completed clinical trial investigating myocardial lipid and creatine in heart failure measured by magnetic resonance spectroscopy.
-
FDA approval · 2019-10-04FDA Approved: DIGOXIN — Original Application (VistaPharm, LLC)
The FDA approved VistaPharm’s original (ANDA) application for digoxin, granting marketing approval for a generic digoxin product.
-
FDA approval · 2019-10-01FDA Approved: ENTRESTO — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for ENTRESTO (sacubitril and valsartan) from Novartis Pharmaceuticals Corporation. This action a…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF) [Phase 4]
Phase 4 trial update on predischarge initiation of ivabradine for heart failure; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: QuickOpt Chronic Study [NA]
Clinical trial update for the QuickOpt Chronic Study in heart failure shows completed status with results posted.
-
FDA approval · 2019-09-26FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC under an ANDA. The action authorizes changes …
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. [Phase 4]
Phase 4 trial comparing sacubitril/valsartan to enalapril on NT-proBNP in patients stabilized after an acute heart failure episode has compl…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study
Clinical trial update on using multipolar coronary sinus lead family ACUITY X4 in the RALLY X4 study for maximizing CRT delivery in heart fa…
-
CLINICAL_TRIALS research · 2019-09-20Clinical Trial Update: Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)
Clinical trial update on optimizing pacing therapy with multi-programmable pulse generators for cardiac resynchronization pacing (CRT-P); st…